Related Experiment Video
Updated: Nov 5, 2025
Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
A Review of CXCL1 in Cardiac Fibrosis
Cheng-Long Wu1, Ran Yin1, Su-Nan Wang1
1Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Insights
Chemokine CXCL1, a pro-inflammatory factor, drives neutrophil infiltration and is linked to organ fibrosis. This review explores CXCL1
Area of Science:
- Cardiovascular Biology
- Inflammation Research
- Fibrosis Mechanisms
Background:
- Chemokine C-X-C motif ligand-1 (CXCL1) is a key pro-inflammatory mediator.
- Elevated CXCL1 serum levels indicate systemic inflammation.
- CXCL1 is implicated in the pathogenesis of fibrosis across various organs.
Approach:
- Review of the structure and physiological functions of CXCL1.
- Analysis of recent research on CXCL1's role in cardiac fibrosis.
- Exploration of CXCL1's involvement in fibrosis of other organs.
Key Points:
- CXCL1 promotes cardiac remodeling and fibrosis.
- Understanding CXCL1 mechanisms in cardiac fibrosis is crucial.
- CXCL1's role extends to fibrosis in organs beyond the heart.
Conclusions:
- CXCL1 is a significant factor in cardiac fibrosis development.
- CXCL1 may represent a therapeutic target for cardiovascular diseases.
- Further research into CXCL1's broader fibrotic roles is warranted.
Abstract:
Chemokine C-X-C motif ligand-1 (CXCL1), principally expressed in neutrophils, macrophages and epithelial cells, is a valid pro-inflammatory factor which performs an important role in mediating the infiltration of neutrophils and monocytes/macrophages. Elevated serum level of CXCL1 is considered a pro-inflammatory reaction by the organism. CXCL1 is also related to diverse organs fibrosis according to relevant studies. A growing body of evidence suggests that CXCL1 promotes the process of cardiac remodeling and fibrosis. Here, we review structure and physiological functions of CXCL1 and recent progress on the effects and mechanisms of CXCL1 in cardiac fibrosis. In addition, we explore the role of CXCL1 in the fibrosis of other organs. Besides, we probe the possibility that CXCL1 can be a therapeutic target for the treatment of cardiac fibrosis in cardiovascular diseases.
